M

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Clinical Systems Specialist - IT

Data EngineeringConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$85k - $105kIn-person

About the Job

Requirements

  • At least 3 years of experience supporting clinical or clinical operations systems, such as EDC, IRT/RTSM, eTMF, or CTMS, in a biotech, pharmaceutical, or CRO environment.
  • Hands-on experience building data pipelines or integrations between clinical/vendor systems and a cloud data platform such as AWS S3, Athena, Glue, or Lambda, or equivalent.
  • Working proficiency in SQL and at least one scripting or automation language.
  • Understanding of clinical data structures and standards, including CDISC SDTM/ODM and EDC data models.
  • A track record of replacing repetitive processes with scripts or pipelines to automate work and reduce manual toil.
  • Working knowledge of data privacy and integrity requirements relevant to clinical data, including 21 CFR Part 11 and GxP data handling.

Responsibilities

  • Administer and support core clinical operations systems, including EDC, IRT/RTSM, eTMF, and CTMS, covering access, study builds, and day-to-day troubleshooting.
  • Serve as the IT point of contact for clinical vendor and CRO systems, coordinating access and data exchange with vendor technical teams.
  • Maintain documentation of clinical system architecture, data flows, and access controls to support audit readiness and data integrity.
  • Design, build, and maintain data pipelines that move clinical, operational, and biomarker/assay data from EDC, IRT, and CRO/lab vendor sources into the data platform.
  • Build and support integrations between clinical systems and downstream consumers, including Clinical Data Science, Biomarkers, and reporting tools.
  • Own ingestion and harmonization of CRO/central-lab assay data into consistent, reusable datasets.
  • Monitor pipeline health and data freshness, proactively resolving failures before they affect downstream analysis.
  • Replace recurring manual work, including CRO file drops, reconciliation, and ad hoc extracts, with scripted, scheduled, or event-driven automation.
  • Build lightweight tooling using Python, SQL, and serverless/Lambda technologies to provide Clinical Data Science and Biomarkers with self-service access to clean, current data.
  • Apply automation and AI/agentic tooling to reduce toil in clinical data operations, and document reusable solutions rather than one-off fixes.
  • Work with the broader IT team on shared priorities, including vendor access reviews, vulnerability remediation, and enterprise support.
  • Represent IT in cross-functional discussions with Clinical Operations, Clinical Data Science, and Biomarkers.

Desired Qualifications

  • Experience with biomarker/translational data platforms or CRO assay data harmonization, such as QuartzBio or TetraScience, and/or CDISC tooling such as Certara Pinnacle 21.
  • Familiarity with workflow orchestration, such as AWS Step Functions, and infrastructure-as-code for productionizing pipelines.
  • Exposure to ELN/LIMS platforms, such as Benchling, and familiarity with data lakes or analytical warehouses.
  • A bachelor's degree in a technical, life sciences, or clinical data field, or equivalent hands-on experience.

About the Company

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Monte Rosa Therapeutics develops molecular glue degraders (MGDs) to treat cancer and autoimmune/inflammatory diseases using its QuEEN discovery engine, a platform that fuses AI-guided chemistry, proteomics, and structural biology to design MGDs. MGDs work by bringing a target protein together with an E3 ligase, tagging the protein for destruction by the cell's proteasome rather than just inhibiting it. The company distinguishes itself with the QuEEN platform, partnerships with Roche and Novartis for joint development and funding, and a portfolio that includes MRT-2359, MRT-6160, and MRT-8102 as clinical-stage programs. Its goal is to discover, develop, and commercialize MGDs, grow its pipeline, and create value through collaborations, upfront payments, milestones, and royalties while delivering treatments for patients with serious diseases.

Company size
201-500
Company stage
IPO
Headquarters
Boston, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Monte Rosa Therapeutics

See more jobs